United States Biotechnology & Medical Research

Novavax, Inc. (NVAX)

Track

Track

Novavax Inc. has recorded no insider trading activity within the last three months. The most recent transactions occurred in May 2026, involving proposed sales by a former officer. Previous historical filings show various divestments by directors and board members, with no significant buying patterns observed during the reported periods.
Ticker: NVAX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Novavax, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ruxandra Draghia Akli Former Officer Officer
Transaction date
Proposed sale
Price
60.17
Quantity 63,265
Value US$2,807,943
Ruxandra Draghia Akli Former Officer Officer
Transaction date
Proposed sale
Price
479.22
Quantity 62,791
Value US$4,570,044
3.0
YOUNG JAMES F Former Director Non-Executive Director
Transaction date
Proposed sale
Price
224.50
Quantity 94,854
Value US$775,904
3.0
YOUNG JAMES F Former Director Non-Executive Director
Transaction date
Proposed sale
Price
6.10
Quantity 4,000
Value US$24,406
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
8.00
Quantity 5,400 -9.4%
Value US$43,200
3.0
YOUNG JAMES F Director Non-Executive Director
Transaction date
Proposed sale
Price
8.48
Quantity 10,000
Value US$84,800
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
8.48
Quantity 4,600 -7.4%
Value US$39,008
3.0
YOUNG JAMES F Director Non-Executive Director
Transaction date
Proposed sale
Price
8.48
Quantity 10,000
Value US$84,800
2.3
King Rachel K. Non-Executive Director
Transaction date
Sale
Price
9.02
Quantity 4,150 -21.9%
Value US$37,435
2.3
Rachel K. King Board Member
Transaction date
Proposed sale
Price
9.00
Quantity 4,150
Value US$37,350
2.6
Dubovsky Filip Officer Officer
Transaction date
Proposed sale
Price
13.00
Quantity 7,335
Value US$95,331
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
14.09
Quantity 7,500 -10.8%
Value US$105,675
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
14.28
Quantity 1,107 -1.6%
Value US$15,808
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
13.62
Quantity 6,393 -8.3%
Value US$87,073
3.0
YOUNG JAMES F Director Non-Executive Director
Transaction date
Proposed sale
Price
13.71
Quantity 15,000
Value US$205,650
2.6
Dubovsky Filip President, R&D Officer
Transaction date
Sale
Price
14.54
Quantity 1,404 -2.1%
Value US$20,414
2.6
Dubovsky Filip President, R&D Officer
Transaction date
Sale
Price
14.46
Quantity 12,500 -15.5%
Value US$180,750
2.6
Dubovsky Filip Officer Officer
Transaction date
Proposed sale
Price
14.47
Quantity 13,904
Value US$201,185
2.6
Dubovsky Filip President, R&D Officer
Transaction date
Sale
Price
13.90
Quantity 47,312 -54.8%
Value US$657,637
2.6
Dubovsky Filip Officer Officer
Transaction date
Proposed sale
Price
13.89
Quantity 47,312
Value US$657,386
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Purchase
Price
6.50
Quantity 1,000 +7.4%
Value US$6,500
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Purchase
Price
7.04
Quantity 2,000 +17.4%
Value US$14,088
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned purchase
Price
7.48
Quantity 3,000 +35.4%
Value US$22,454
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
75.10
Quantity 300 -0.5%
Value US$22,531
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
74.25
Quantity 3,255 -4.9%
Value US$241,684
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
73.29
Quantity 8,945 -11.9%
Value US$655,550
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
144.43
Quantity 100 -2.5%
Value US$14,443
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
143.64
Quantity 1,003 -20.3%
Value US$144,070
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
142.65
Quantity 800 -13.9%
Value US$114,117
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
141.69
Quantity 800 -12.2%
Value US$113,350
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
140.05
Quantity 500 -7.1%
Value US$70,026
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
139.08
Quantity 997 -12.4%
Value US$138,660
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
137.85
Quantity 400 -4.7%
Value US$55,140
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
136.82
Quantity 400 -4.5%
Value US$54,728
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
144.16
Quantity 3,750 -4.8%
Value US$540,601
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
230.00
Quantity 5,000 -56.5%
Value US$1,150,000
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
180.62
Quantity 27 -0.5%
Value US$4,877
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
179.58
Quantity 206 -3.5%
Value US$36,993
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
178.99
Quantity 103 -1.7%
Value US$18,436
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
176.83
Quantity 223 -3.6%
Value US$39,432
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
175.89
Quantity 67 -1.1%
Value US$11,785
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
174.65
Quantity 137 -2.1%
Value US$23,927
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
173.29
Quantity 91 -1.4%
Value US$15,770
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
172.38
Quantity 248 -3.7%
Value US$42,750
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
171.47
Quantity 254 -3.6%
Value US$43,553
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
170.46
Quantity 213 -2.9%
Value US$36,309
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
168.82
Quantity 117 -1.6%
Value US$19,752
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
182.96
Quantity 100 -2.4%
Value US$18,296
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
182.30
Quantity 853 -17.0%
Value US$155,498
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
180.29
Quantity 500 -9.1%
Value US$90,147
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
179.36
Quantity 500 -8.3%
Value US$89,680
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
178.21
Quantity 500 -7.7%
Value US$89,104
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
176.20
Quantity 800 -10.9%
Value US$140,956
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
175.13
Quantity 900 -11.0%
Value US$157,619
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
173.14
Quantity 200 -2.4%
Value US$34,627
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
171.30
Quantity 200 -2.3%
Value US$34,260
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
168.77
Quantity 400 -4.4%
Value US$67,508
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
167.06
Quantity 300 -3.2%
Value US$50,118
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
165.80
Quantity 300 -3.1%
Value US$49,739
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
164.77
Quantity 300 -3.0%
Value US$49,430
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
162.83
Quantity 200 -2.0%
Value US$32,565
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
161.63
Quantity 300 -2.9%
Value US$48,490
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
160.52
Quantity 300 -2.8%
Value US$48,157
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
158.42
Quantity 300 -2.7%
Value US$47,527
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
157.02
Quantity 200 -1.8%
Value US$31,404
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
156.24
Quantity 300 -2.6%
Value US$46,873
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
154.38
Quantity 100 -0.9%
Value US$15,438
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
153.53
Quantity 397 -3.3%
Value US$60,951
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
151.85
Quantity 100 -0.8%
Value US$15,185
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
150.30
Quantity 200 -1.6%
Value US$30,059
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
202.36
Quantity 366 -11.7%
Value US$74,064
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
200.92
Quantity 300 -8.8%
Value US$60,276
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
199.81
Quantity 300 -8.1%
Value US$59,944
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
198.35
Quantity 400 -9.7%
Value US$79,340
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
197.19
Quantity 300 -6.8%
Value US$59,156
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-27 2026-05-27 PrS Proposed sale
Ruxandra Draghia Akli

Former Officer

Officer
63,265
60.17
US$2,807,943 		63,265 60.17 US$2,807,943
2026-05-07 2026-05-07 PrS Proposed sale
Ruxandra Draghia Akli

Former Officer

Officer
62,791
479.22
US$4,570,044 		62,791 479.22 US$4,570,044
2025-05-19 2025-05-19 PrS Proposed sale
3.0
YOUNG JAMES F

Former Director

Non-Executive Director
94,854
224.50
US$775,904 		94,854 224.50 US$775,904
2025-04-14 2025-04-14 PrS Proposed sale
3.0
YOUNG JAMES F

Former Director

Non-Executive Director
4,000
6.10
US$24,406 		4,000 6.10 US$24,406
2025-01-02 2024-12-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
5,400 -9.4%
8.00
US$43,200 		5,400 -9.4% 8.00 US$43,200
2025-01-02 2024-12-24 PrS Proposed sale
3.0
YOUNG JAMES F

Director

Non-Executive Director
10,000
8.48
US$84,800 		10,000 8.48 US$84,800
2025-01-02 2024-12-24 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
4,600 -7.4%
8.48
US$39,008 		4,600 -7.4% 8.48 US$39,008
2024-12-26 2024-12-24 PrS Proposed sale
3.0
YOUNG JAMES F

Director

Non-Executive Director
10,000
8.48
US$84,800 		10,000 8.48 US$84,800
2025-01-02 2024-12-13 S Sale
2.3
King Rachel K.
Non-Executive Director
4,150 -21.9%
9.02
US$37,435 		4,150 -21.9% 9.02 US$37,435
2024-12-13 2024-12-13 PrS Proposed sale
2.3
Rachel K. King

Board Member
4,150
9.00
US$37,350 		4,150 9.00 US$37,350
2024-09-18 2024-09-18 PrS Proposed sale
2.6
Dubovsky Filip

Officer

Officer
7,335
13.00
US$95,331 		7,335 13.00 US$95,331
2024-06-25 2024-06-21 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
7,500 -10.8%
14.09
US$105,675 		7,500 -10.8% 14.09 US$105,675
2024-06-21 2024-06-18 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
1,107 -1.6%
14.28
US$15,808 		1,107 -1.6% 14.28 US$15,808
2024-06-21 2024-06-18 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
6,393 -8.3%
13.62
US$87,073 		6,393 -8.3% 13.62 US$87,073
2024-06-18 2024-06-18 PrS Proposed sale
3.0
YOUNG JAMES F

Director

Non-Executive Director
15,000
13.71
US$205,650 		15,000 13.71 US$205,650
2024-06-20 2024-06-17 S Sale
2.6
Dubovsky Filip

President, R&D

Officer
1,404 -2.1%
14.54
US$20,414 		1,404 -2.1% 14.54 US$20,414
2024-06-20 2024-06-17 S Sale
2.6
Dubovsky Filip

President, R&D

Officer
12,500 -15.5%
14.46
US$180,750 		12,500 -15.5% 14.46 US$180,750
2024-06-17 2024-06-17 PrS Proposed sale
2.6
Dubovsky Filip

Officer

Officer
13,904
14.47
US$201,185 		13,904 14.47 US$201,185
2024-05-15 2024-05-14 S Sale
2.6
Dubovsky Filip

President, R&D

Officer
47,312 -54.8%
13.90
US$657,637 		47,312 -54.8% 13.90 US$657,637
2024-05-14 2024-05-14 PrS Proposed sale
2.6
Dubovsky Filip

Officer

Officer
47,312
13.89
US$657,386 		47,312 13.89 US$657,386
2023-03-14 2023-03-10 B Purchase
2.9
Glenn Gregory M

President, R&D

Officer
1,000 +7.4%
6.50
US$6,500 		1,000 +7.4% 6.50 US$6,500
2023-03-14 2023-03-07 B Purchase
2.9
Glenn Gregory M

President, R&D

Officer
2,000 +17.4%
7.04
US$14,088 		2,000 +17.4% 7.04 US$14,088
2023-03-14 2023-03-06 PP Planned purchase
2.9
Glenn Gregory M

President, R&D

Officer
3,000 +35.4%
7.48
US$22,454 		3,000 +35.4% 7.48 US$22,454
2022-04-04 2022-03-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
300 -0.5%
75.10
US$22,531 		300 -0.5% 75.10 US$22,531
2022-04-04 2022-03-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
3,255 -4.9%
74.25
US$241,684 		3,255 -4.9% 74.25 US$241,684
2022-04-04 2022-03-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
8,945 -11.9%
73.29
US$655,550 		8,945 -11.9% 73.29 US$655,550
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
100 -2.5%
144.43
US$14,443 		100 -2.5% 144.43 US$14,443
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
1,003 -20.3%
143.64
US$144,070 		1,003 -20.3% 143.64 US$144,070
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
800 -13.9%
142.65
US$114,117 		800 -13.9% 142.65 US$114,117
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
800 -12.2%
141.69
US$113,350 		800 -12.2% 141.69 US$113,350
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
500 -7.1%
140.05
US$70,026 		500 -7.1% 140.05 US$70,026
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
997 -12.4%
139.08
US$138,660 		997 -12.4% 139.08 US$138,660
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
400 -4.7%
137.85
US$55,140 		400 -4.7% 137.85 US$55,140
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
400 -4.5%
136.82
US$54,728 		400 -4.5% 136.82 US$54,728
2022-01-04 2021-12-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
3,750 -4.8%
144.16
US$540,601 		3,750 -4.8% 144.16 US$540,601
2021-12-22 2021-12-20 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
5,000 -56.5%
230.00
US$1,150,000 		5,000 -56.5% 230.00 US$1,150,000
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
27 -0.5%
180.62
US$4,877 		27 -0.5% 180.62 US$4,877
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
206 -3.5%
179.58
US$36,993 		206 -3.5% 179.58 US$36,993
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
103 -1.7%
178.99
US$18,436 		103 -1.7% 178.99 US$18,436
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
223 -3.6%
176.83
US$39,432 		223 -3.6% 176.83 US$39,432
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
67 -1.1%
175.89
US$11,785 		67 -1.1% 175.89 US$11,785
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
137 -2.1%
174.65
US$23,927 		137 -2.1% 174.65 US$23,927
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
91 -1.4%
173.29
US$15,770 		91 -1.4% 173.29 US$15,770
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
248 -3.7%
172.38
US$42,750 		248 -3.7% 172.38 US$42,750
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
254 -3.6%
171.47
US$43,553 		254 -3.6% 171.47 US$43,553
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
213 -2.9%
170.46
US$36,309 		213 -2.9% 170.46 US$36,309
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
117 -1.6%
168.82
US$19,752 		117 -1.6% 168.82 US$19,752
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
100 -2.4%
182.96
US$18,296 		100 -2.4% 182.96 US$18,296
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
853 -17.0%
182.30
US$155,498 		853 -17.0% 182.30 US$155,498
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
500 -9.1%
180.29
US$90,147 		500 -9.1% 180.29 US$90,147
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
500 -8.3%
179.36
US$89,680 		500 -8.3% 179.36 US$89,680
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
500 -7.7%
178.21
US$89,104 		500 -7.7% 178.21 US$89,104
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
800 -10.9%
176.20
US$140,956 		800 -10.9% 176.20 US$140,956
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
900 -11.0%
175.13
US$157,619 		900 -11.0% 175.13 US$157,619
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -2.4%
173.14
US$34,627 		200 -2.4% 173.14 US$34,627
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -2.3%
171.30
US$34,260 		200 -2.3% 171.30 US$34,260
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
400 -4.4%
168.77
US$67,508 		400 -4.4% 168.77 US$67,508
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -3.2%
167.06
US$50,118 		300 -3.2% 167.06 US$50,118
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -3.1%
165.80
US$49,739 		300 -3.1% 165.80 US$49,739
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -3.0%
164.77
US$49,430 		300 -3.0% 164.77 US$49,430
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -2.0%
162.83
US$32,565 		200 -2.0% 162.83 US$32,565
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.9%
161.63
US$48,490 		300 -2.9% 161.63 US$48,490
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.8%
160.52
US$48,157 		300 -2.8% 160.52 US$48,157
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.7%
158.42
US$47,527 		300 -2.7% 158.42 US$47,527
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -1.8%
157.02
US$31,404 		200 -1.8% 157.02 US$31,404
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.6%
156.24
US$46,873 		300 -2.6% 156.24 US$46,873
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
100 -0.9%
154.38
US$15,438 		100 -0.9% 154.38 US$15,438
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
397 -3.3%
153.53
US$60,951 		397 -3.3% 153.53 US$60,951
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
100 -0.8%
151.85
US$15,185 		100 -0.8% 151.85 US$15,185
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -1.6%
150.30
US$30,059 		200 -1.6% 150.30 US$30,059
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
366 -11.7%
202.36
US$74,064 		366 -11.7% 202.36 US$74,064
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
300 -8.8%
200.92
US$60,276 		300 -8.8% 200.92 US$60,276
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
300 -8.1%
199.81
US$59,944 		300 -8.1% 199.81 US$59,944
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
400 -9.7%
198.35
US$79,340 		400 -9.7% 198.35 US$79,340
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
300 -6.8%
197.19
US$59,156 		300 -6.8% 197.19 US$59,156
Explore more

More insider trading research around Novavax, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America